The etiology of urolithiasis in HIV infected patients

Journal of Urology

Volumn 169, Issue 2, 2003, Pages 475-477

  Nadler, Robert B ^a   Rubenstein, Jonathan N ^a   Eggener, Scott E ^a   Loor, Michelle M ^a   Smith, Norm D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

HIV; Kidney calculi; Protease inhibitors

Indexed keywords

ANTIRETROVIRUS AGENT; CALCIUM OXALATE; CALCIUM PHOSPHATE; INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; URIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICOSURIA; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; PROTEINASE INHIBITION; RETROSPECTIVE STUDY; STONE FORMATION; URETEROSCOPY; URINALYSIS; VIRUS INFECTION;

EID: 0037305779     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)63936-5     Document Type: Article

References (11)

1. Gentle, D. L., Stoller, M. L., Jarret, T. W., Ward, J. F., Geib, K. S. and Wood, A. F.: Protease inhibitor-induced urolithiasis. Urology, 50: 508, 1997
2. Sundaram, C. P. and Saltzman, B.: Urolithiasis associated with protease inhibitors. J Endourol, 13: 309, 1999
3. Nelson, H.: Protease inhibitors show promise in HIV infection. Lancet, 347: 383, 1996
4. Brodie, S. B., Keller, M. J., Ewenstein, B. M. and Sax, P. E.: Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients. AIDS, 12: 2433, 1998
5. Reiter, W. J., Schön-Pernerstorfer, H., Dorfinger, K., Hofbauer, J. and Marberger, M.: Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed. J Urol, 161: 1082, 1999
6. Sutherland, S. E., Reigle, M. D., Seftel, A. D. and Resnick, M. I.: Protease inhibitors and urolithiasis. J Urol, 158: 31, 1997
7. Malavaud, B., Dinh, B., Bonnet, E., Izopet, J., Payen, J. L. and Marchou, B.: Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection. Antivir Ther, 5: 3, 2000
8. Schwartz, B. F., Schenkman, N., Armenakas, N. A. and Stoller, M. L.: Imaging characteristics of indinavir calculi. J Urol, 161: 1085, 1999
9. Polhemus, M. E. and Aronson, N. E.: Persistent nephrolithiasis after discontinuation of indinavir therapy. Clin Infect Dis, 27: 1536, 1998
10. Rich, J. D., Ramratnam, B., Chiang, M. and Tashima, K. T.: Management of indinavir associated nephrolithiasis. J Urol, 158: 2228, 1997
11. Gagnon, R. F., Tecimer, S. N., Watters, A. K. and Tsoukas, C. M.: Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir. Am J Kidney Dis, 36: 507, 2000 478-479